{"date":"2025-09-15","count":19,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4114-2025-09-15-2118-1lud6w4","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2025-09-15","time":"21:18:02","subject":"公告本公司召開重大訊息記者會新聞稿內容","clause":"第53款","fact_date":"2025-09-15","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2025-09-15 21:18，「公告本公司召開重大訊息記者會新聞稿內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2025-09-15-2100-1nj0qmh","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2025-09-15","time":"21:00:08","subject":"公告本公司公開收購健亞生物科技股份有限公司之普通股股份","clause":"第11款","fact_date":"2025-09-15","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2025-09-15 21:00，「公告本公司公開收購健亞生物科技股份有限公司之普通股股份」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-09-15-2010-nipl3a","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-09-15","time":"20:10:14","subject":"公告本公司114年8月份自結應收帳款餘額及回收情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-09-15 20:10，「公告本公司114年8月份自結應收帳款餘額及回收情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2025-09-15-1741-11et61j","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2025-09-15","time":"17:41:36","subject":"公告本公司114年度股東臨時會通過解除新任第八屆獨立董事競業禁止之限制案","clause":"第21款","fact_date":"2025-09-15","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2025-09-15 17:41，「公告本公司114年度股東臨時會通過解除新任第八屆獨立董事競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4120-2025-09-15-1739-1y0peq8","company_id":"4120","company":"友華","market":"上櫃","industry":"生技醫療","date":"2025-09-15","time":"17:39:30","subject":"公告本公司董事會決議參與認購100%子公司友杏生技醫藥股份有限公司現金增資普通股案","clause":"第20款","fact_date":"2025-09-15","cite_as":"公開資訊觀測站重大訊息：友華（4120），2025-09-15 17:39，「公告本公司董事會決議參與認購100%子公司友杏生技醫藥股份有限公司現金增資普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2025-09-15-1736-1xdzl4i","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2025-09-15","time":"17:36:56","subject":"公告本公司114年股東臨時會補選增加獨立董事一席","clause":"第6款","fact_date":"2025-09-15","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2025-09-15 17:36，「公告本公司114年股東臨時會補選增加獨立董事一席」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2025-09-15-1732-1m9yg14","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2025-09-15","time":"17:32:41","subject":"公告本公司審計委員會成員異動","clause":"第6款","fact_date":"2025-09-15","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2025-09-15 17:32，「公告本公司審計委員會成員異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4120-2025-09-15-1732-1ot52kt","company_id":"4120","company":"友華","market":"上櫃","industry":"生技醫療","date":"2025-09-15","time":"17:32:13","subject":"代重要子公司友杏生技醫藥股份有限公司公告現金增資基準日","clause":"第11款","fact_date":"2025-09-15","cite_as":"公開資訊觀測站重大訊息：友華（4120），2025-09-15 17:32，「代重要子公司友杏生技醫藥股份有限公司公告現金增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2025-09-15-1730-jgb7do","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2025-09-15","time":"17:30:02","subject":"公告本公司114年度股東臨時會重要決議事項","clause":"第18款","fact_date":"2025-09-15","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2025-09-15 17:30，「公告本公司114年度股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7773-2025-09-15-1728-hlxb99","company_id":"7773","company":"富禾生醫","market":"興櫃","industry":"生技醫療","date":"2025-09-15","time":"17:28:56","subject":"公告本公司內部稽核主管任命案","clause":"第11款","fact_date":"2025-09-15","cite_as":"公開資訊觀測站重大訊息：富禾生醫（7773），2025-09-15 17:28，「公告本公司內部稽核主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-09-15-1726-16sohr8","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-09-15","time":"17:26:25","subject":"本公司受邀參加元大證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2025-09-16","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-09-15 17:26，「本公司受邀參加元大證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2025-09-15-1725-ovlw6p","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2025-09-15","time":"17:25:34","subject":"公告本公司將召開投資人可參與之重大訊息說明會","clause":"第53款","fact_date":"2025-09-15","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2025-09-15 17:25，「公告本公司將召開投資人可參與之重大訊息說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3118-2025-09-15-1629-16sohr8","company_id":"3118","company":"進階","market":"上櫃","industry":"生技醫療","date":"2025-09-15","time":"16:29:48","subject":"本公司受邀參加元大證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2025-09-16","cite_as":"公開資訊觀測站重大訊息：進階（3118），2025-09-15 16:29，「本公司受邀參加元大證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6733-2025-09-15-1546-2i4mxm","company_id":"6733","company":"博晟生醫","market":"上櫃","industry":"生技醫療","date":"2025-09-15","time":"15:46:44","subject":"公告本公司接獲骨生長因子台美二期臨床試驗結果","clause":"第53款","fact_date":"2025-09-15","cite_as":"公開資訊觀測站重大訊息：博晟生醫（6733），2025-09-15 15:46，「公告本公司接獲骨生長因子台美二期臨床試驗結果」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6733-2025-09-15-1542-1y0nxc4","company_id":"6733","company":"博晟生醫","market":"上櫃","industry":"生技醫療","date":"2025-09-15","time":"15:42:17","subject":"本公司今日召開重大訊息記者會之新聞稿內容","clause":"第53款","fact_date":"2025-09-15","cite_as":"公開資訊觀測站重大訊息：博晟生醫（6733），2025-09-15 15:42，「本公司今日召開重大訊息記者會之新聞稿內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2025-09-15-1516-1p6ebts","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2025-09-15","time":"15:16:38","subject":"代子公司共信醫藥科技股份有限公司及天津紅日健達康醫藥科技有限公司公告與I公司正式簽訂本公司產品PTS302於阿爾及利亞地區之授權及經銷合約。","clause":"第10款","fact_date":"2025-09-15","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2025-09-15 15:16，「代子公司共信醫藥科技股份有限公司及天津紅日健達康醫藥科技有限公司公告與I公司正式簽訂本公司產品PTS302於阿爾及利亞地」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2025-09-15-1458-ryc5qx","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2025-09-15","time":"14:58:23","subject":"公告本公司將於114年09月23日召開改列上市前業績發表會","clause":"第12款","fact_date":"2025-09-23","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2025-09-15 14:58，「公告本公司將於114年09月23日召開改列上市前業績發表會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4161-2025-09-15-1423-i6olxw","company_id":"4161","company":"聿新科","market":"上櫃","industry":"生技醫療","date":"2025-09-15","time":"14:23:35","subject":"公告本公司註銷限制員工權利新股註銷減資變更登記完成","clause":"第36款","fact_date":"2025-09-15","cite_as":"公開資訊觀測站重大訊息：聿新科（4161），2025-09-15 14:23，「公告本公司註銷限制員工權利新股註銷減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6733-2025-09-15-1003-2u9j09","company_id":"6733","company":"博晟生醫","market":"上櫃","industry":"生技醫療","date":"2025-09-15","time":"10:03:53","subject":"公告本公司召開重大訊息記者會內容","clause":"第53款","fact_date":"2025-09-15","cite_as":"公開資訊觀測站重大訊息：博晟生醫（6733），2025-09-15 10:03，「公告本公司召開重大訊息記者會內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}